Published in Br J Cancer on March 01, 1993
Inflammatory breast cancer: clinical progress and the main problems that must be addressed. Breast Cancer Res (2003) 1.28
Concomitant intensive chemoradiotherapy induction in non-metastatic inflammatory breast cancer: long-term follow-up. Br J Cancer (2007) 0.84
Evaluation of survival data and two new rank order statistics arising in its consideration. Cancer Chemother Rep (1966) 48.83
Reporting results of cancer treatment. Cancer (1981) 28.83
Multimodal treatment for inflammatory breast cancer. Int J Radiat Oncol Biol Phys (1989) 2.09
Pathological assessment of response to induction chemotherapy in breast cancer. Cancer Res (1986) 1.82
Neoadjuvant chemotherapy in the combined modality approach of locally advanced nonmetastatic breast cancer. Cancer Res (1987) 1.54
Inflammatory carcinoma of the breast. Cancer (1978) 1.12
Dose-intensity meta-analysis of chemotherapy regimens in small-cell carcinoma of the lung. J Clin Oncol (1991) 1.06
Continuous 5-fluorouracil infusion in refractory carcinoma of the breast. Breast Cancer Res Treat (1987) 1.05
Primary chemotherapy in the treatment of inflammatory breast carcinoma: a study of 230 cases from the Institut Gustave-Roussy. J Clin Oncol (1986) 1.05
Inflammatory carcinoma of the breast: the case for conservatism. Am J Surg (1976) 0.94
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer (1987) 0.93
Applications of dose intensity to problems in chemotherapy of breast and colorectal cancer. Semin Oncol (1987) 0.90
Treatment of patients with inflammatory breast cancer. Important Adv Oncol (1989) 0.84
Prognostic factors in inflammatory breast cancer. Univariate and multivariate analysis. Cancer (1989) 0.83
Results of initial doxorubicin, 5-fluorouracil, and cyclophosphamide combination chemotherapy for inflammatory carcinoma of the breast. Cancer (1990) 0.83
Management of inflammatory carcinoma of the breast. A combined modality approach. Am J Clin Oncol (1985) 0.82
Surgery as part of a combined modality approach for inflammatory breast carcinoma. Cancer (1987) 0.82
Stimulation of breast cancer with estrogens: how much clinical value? Eur J Cancer Clin Oncol (1987) 0.80
Therapeutic strategies in inflammatory breast carcinoma based on prognostic factors. Breast Cancer Res Treat (1990) 0.79
Chemotherapy with estrogenic recruitment and surgery in locally advanced breast cancer: clinical and cytokinetic results. Int J Cancer (1987) 0.78
Role of surgery in the treatment of inflammatory breast carcinoma. Am J Surg (1984) 0.78
Inflammatory breast cancer treated with surgery, chemotherapy and allogeneic tumor cell/BCG immunotherapy. Cancer (1982) 0.78
Progress in inflammatory breast cancer: cause for cautious optimism. J Clin Oncol (1986) 0.78
Preliminary results of primary systemic chemotherapy in association with surgery or radiotherapy in rapidly progressing breast cancer. Br J Cancer (1982) 0.78
[Cancer of the breast: intensive treatment with bone marrow autografts]. Bull Cancer (1989) 0.77
Role of chemotherapy in acute breast cancer. Analysis of 41 cases. Int Surg (1988) 0.77
Preoperative chemotherapy in primary operable breast cancer: results from the European Organization for Research and Treatment of Cancer trial 10902. J Clin Oncol (2001) 5.28
Defective axonal transport in a transgenic mouse model of amyotrophic lateral sclerosis. Nature (1995) 2.83
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: analysis of European Organization for Research and Treatment of Cancer Trial 10853. J Clin Oncol (2001) 2.51
Impaired learning and LTP in mice expressing the carboxy terminus of the Alzheimer amyloid precursor protein. Nature (1997) 2.44
Progressive neuronopathy in transgenic mice expressing the human neurofilament heavy gene: a mouse model of amyotrophic lateral sclerosis. Cell (1993) 2.42
Multiple phosphorylation sites in mammalian neurofilament polypeptides. J Biol Chem (1982) 2.34
Delayed maturation of regenerating myelinated axons in mice lacking neurofilaments. Exp Neurol (1997) 2.11
The structure of a human neurofilament gene (NF-L): a unique exon-intron organization in the intermediate filament gene family. Biochim Biophys Acta (1987) 2.10
Results of sphincteroplasty in 86 patients with anal incontinence. Dis Colon Rectum (2000) 2.03
[Liver transplantation in the pig: surgical approach]. C R Acad Sci Hebd Seances Acad Sci D (1965) 1.98
Deregulation of Cdk5 in a mouse model of ALS: toxicity alleviated by perikaryal neurofilament inclusions. Neuron (2001) 1.68
The distribution of phosphorylation sites among identified proteolytic fragments of mammalian neurofilaments. J Biol Chem (1983) 1.68
Ductal carcinoma in situ of the male breast. Analysis of 31 cases. Eur J Cancer (1997) 1.67
An improved CAT assay for promoter analysis in either transgenic mice or tissue culture cells. DNA Cell Biol (1992) 1.59
Translocations involving band 3q27 and Ig gene regions in non-Hodgkin's lymphoma. Blood (1992) 1.59
Does age play a role in clinical presentation of hypothyroidism? J Am Geriatr Soc (1994) 1.57
Integrators of the cytoskeleton that stabilize microtubules. Cell (1999) 1.56
Breast cancer in patients treated for Hodgkin's disease: clinical and pathological analysis of 76 cases in 63 patients. Eur J Cancer (1997) 1.53
Male breast cancer: results of the treatments and prognostic factors in 397 cases. Eur J Cancer (1995) 1.48
Effects of polyethylene glycol 4000 on 24-h manometric recordings of left colonic motor activity. Eur J Gastroenterol Hepatol (2001) 1.46
Prolonged stationary colonic motility recording in seven patients with severe constipation secondary to antidepressants. Neurogastroenterol Motil (2000) 1.45
Variations in diagnostic and therapeutic procedures in a multicentre, randomized clinical trial (EORTC 10853) investigating breast-conserving treatment for DCIS. Eur J Surg Oncol (2001) 1.44
Improved local control and disease-free survival after perioperative chemotherapy for early-stage breast cancer. A European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group Study. J Clin Oncol (1996) 1.42
Variants of the heavy neurofilament subunit are associated with the development of amyotrophic lateral sclerosis. Hum Mol Genet (1994) 1.42
Influence of pregnancy on the outcome of breast cancer: a case-control study. Societe Francaise de Senologie et de Pathologie Mammaire Study Group. Int J Cancer (1997) 1.29
Cloning and developmental expression of the murine neurofilament gene family. Brain Res (1986) 1.28
Differences in the signs and symptoms of hyperthyroidism in older and younger patients. J Am Geriatr Soc (1996) 1.23
Absence of neurofilaments reduces the selective vulnerability of motor neurons and slows disease caused by a familial amyotrophic lateral sclerosis-linked superoxide dismutase 1 mutant. Proc Natl Acad Sci U S A (1998) 1.23
Hyaluronan (hyaluronic acid) and hyaluronectin in the extracellular matrix of human breast carcinomas: comparison between invasive and non-invasive areas. Int J Cancer (1992) 1.22
Workplace bullying and sleep disturbances: findings from a large scale cross-sectional survey in the French working population. Sleep (2009) 1.19
Nerve growth factor activates Thy-1 and neurofilament gene transcription in rat PC12 cells. EMBO J (1986) 1.19
SOD1 mutation is associated with accumulation of neurofilaments in amyotrophic lateral sclerosis. Ann Neurol (1996) 1.19
Disruption of type IV intermediate filament network in mice lacking the neurofilament medium and heavy subunits. J Neurochem (1999) 1.18
Prognostic value of estrogen and progesterone receptors in operable breast cancer. Results of a univariate and multivariate analysis. Cancer (1988) 1.17
Rheumatoid factor is the strongest predictor of radiological progression of rheumatoid arthritis in a three-year prospective study in community-recruited patients. Rheumatology (Oxford) (2003) 1.16
Late onset of motor neurons in mice overexpressing wild-type peripherin. J Cell Biol (1999) 1.16
Breast-conserving therapy for Paget disease of the nipple: a prospective European Organization for Research and Treatment of Cancer study of 61 patients. Cancer (2001) 1.16
Disruption of the NF-H gene increases axonal microtubule content and velocity of neurofilament transport: relief of axonopathy resulting from the toxin beta,beta'-iminodipropionitrile. J Cell Biol (1998) 1.14
Protective effect of neurofilament heavy gene overexpression in motor neuron disease induced by mutant superoxide dismutase. Proc Natl Acad Sci U S A (1998) 1.11
[Breast cancer in men: incidence and types of associated previous synchronous and metachronous cancers]. Bull Cancer (1992) 1.11
Induction of proinflammatory molecules in mice with amyotrophic lateral sclerosis: no requirement for proapoptotic interleukin-1beta in neurodegeneration. Ann Neurol (2001) 1.08
Transcutaneous electrical tibial nerve stimulation in the treatment of fecal incontinence: a randomized trial (CONSORT 1a). Am J Gastroenterol (2012) 1.08
Prognostic value of chromosomal abnormalities in follicular lymphoma. Blood (1994) 1.07
Adjuvant tamoxifen in postmenopausal breast cancer: preliminary results of a randomized trial. Breast Cancer Res Treat (1986) 1.06
Improved survival after one course of perioperative chemotherapy in early breast cancer patients. long-term results from the European Organization for Research and Treatment of Cancer (EORTC) Trial 10854. Eur J Cancer (2001) 1.05
Activation of the p38MAPK cascade is associated with upregulation of TNF alpha receptors in the spinal motor neurons of mouse models of familial ALS. Mol Cell Neurosci (2005) 1.04
Non-Hodgkin's lymphoma of the testis: a retrospective study of 84 patients treated in the French anticancer centres. Ann Oncol (2001) 1.01
Electrophysiological properties of axons in mice lacking neurofilament subunit genes: disparity between conduction velocity and axon diameter in absence of NF-H. Brain Res (2000) 1.00
Susceptibility of Mycobacterium avium complex to various two-drug combinations of antituberculosis agents. Am Rev Respir Dis (1988) 1.00
Breast cancer occurred after treatment for Hodgkin's disease: analysis of 133 cases. Radiother Oncol (2001) 1.00
Prognostic factors in low tumour mass asymptomatic multiple myeloma: a report on 91 patients. The Groupe d'Etudes et de Recherche sur le Myélome (GERM). Am J Hematol (1995) 0.99
A prognostic score in histological node negative breast cancer. Br J Cancer (1990) 0.98
Thromboembolic complications after perioperative chemotherapy in women with early breast cancer: a European Organization for Research and Treatment of Cancer Breast Cancer Cooperative Group study. J Clin Oncol (1994) 0.97
Comparison between endoscopic and surgical sampling for the measurement of potential doubling time in colorectal cancer. Cytometry (1997) 0.97
Influence of the delay of adjuvant postoperative radiation therapy on relapse and survival in oropharyngeal and hypopharyngeal cancers. Int J Radiat Oncol Biol Phys (2001) 0.96
Characteristics of the protein kinase activity associated with rat neurofilament preparations. Biochim Biophys Acta (1983) 0.95
Neuron-specific expression of Cre recombinase during the late phase of brain development. Neurosci Res (2001) 0.95
A new concept for hepatic lobectomy. Experimental studies and clinical application. Arch Surg (1971) 0.94
Predictive factors for successful sacral nerve stimulation in the treatment of faecal incontinence: results of trial stimulation in 200 patients. Colorectal Dis (2010) 0.94
Inflammatory breast cancer. Determination of prognostic factors by univariate and multivariate analysis. Cancer (1987) 0.93
Cloning of a cDNA encoding the smallest neurofilament protein from the rat. Biochim Biophys Acta (1985) 0.93
Apoptotic death of neurons exhibiting peripherin aggregates is mediated by the proinflammatory cytokine tumor necrosis factor-alpha. J Cell Biol (2001) 0.92
Oxidative stress, mutant SOD1, and neurofilament pathology in transgenic mouse models of human motor neuron disease. Lab Invest (1997) 0.92
Extra neurofilament NF-L subunits rescue motor neuron disease caused by overexpression of the human NF-H gene in mice. J Neuropathol Exp Neurol (1999) 0.92
Formation of intermediate filament protein aggregates with disparate effects in two transgenic mouse models lacking the neurofilament light subunit. J Neurosci (2000) 0.91
Altered expression of genes for amyloid and cytoskeletal proteins in Alzheimer cortex. Ann Neurol (1989) 0.91
Interactions between peripherin and neurofilaments in cultured cells: disruption of peripherin assembly by the NF-M and NF-H subunits. Biochem Cell Biol (1999) 0.91
Serum hyaluronan (hyaluronic acid) in breast cancer patients. Int J Cancer (1990) 0.90
A key role for GAP-43 in the retinotectal topographic organization. Exp Neurol (1999) 0.90
Group B streptococcal bacteraemia in the elderly. J Med Microbiol (1998) 0.90
Severe neuronal losses with age in the parietal cortex and ventrobasal thalamus of mice transgenic for the human NF-L neurofilament protein. J Comp Neurol (1999) 0.88
Dinucleotide repeat polymorphism at the D22S264 locus. Nucleic Acids Res (1992) 0.88
Isolation of a zinc finger gene consistently deleted in DiGeorge syndrome. Hum Mol Genet (1993) 0.87
Predicting cancer-associated anaemia in patients receiving non-platinum chemotherapy: results of a retrospective survey. Eur J Cancer (2001) 0.87
Prospective evaluation of the frequency and clinical significance of antineutrophil cytoplasmic and anticardiolipin antibodies in community cases of patients with rheumatoid arthritis. Rheumatology (Oxford) (2000) 0.87
Neurofilaments and motor neuron disease. Trends Cell Biol (1997) 0.87
Renal function and alterations in plasma electrolyte levels in normocalcaemic and hypercalaemic patients with malignant diseases, given an intravenous infusion of mithramycin. Chemotherapy (1974) 0.87
Intragenic regulatory elements contribute to transcriptional control of the neurofilament light gene. Gene (1992) 0.86
Reduction of axonal caliber does not alleviate motor neuron disease caused by mutant superoxide dismutase 1. Proc Natl Acad Sci U S A (2000) 0.86
Workplace bullying and psychotropic drug use: the mediating role of physical and mental health status. Ann Occup Hyg (2010) 0.86
VAD or VMBCP in severe multiple myeloma. The Groupe d'Etudes et de Recherche sur le Myélome (GERM). Br J Haematol (1992) 0.85
A study of long-term survival, functional outcome and quality of life in patients with polymyositis or dermatomyositis. Rev Rhum Engl Ed (1996) 0.84
A comparison of in vitro- and in vivo-phosphorylated neurofilament polypeptides. J Neurochem (1981) 0.84
Altered levels and distribution of microtubule-associated proteins before disease onset in a mouse model of amyotrophic lateral sclerosis. J Neurochem (2003) 0.84
A novel cdc2-related protein kinase expressed in the nervous system. J Neurochem (1997) 0.84
Iatrogenic risks of endometrial carcinoma after treatment for breast cancer in a large French case-control study. Fédération Nationale des Centres de Lutte Contre le Cancer (FNCLCC). Int J Cancer (1998) 0.83
Reasons for non-entry of patients with DCIS of the breast into a randomised trial (EORTC 10853). Eur J Cancer (1991) 0.83
VP-16, cisplatin, doxorubicin, and bleomycin in metastatic Merkel cell carcinoma. Report of a case with long-term remission. Am J Clin Oncol (1993) 0.83
[Consequences of oocyte dysmorphy on the fertilization rate and embryo development after intracytoplasmic sperm injection. A prospective multicenter study]. Gynecol Obstet Fertil (2002) 0.83
Regional distribution of monoamine vesicular uptake sites in the mesencephalon of control subjects and patients with Parkinson's disease: a postmortem study using tritiated tetrabenazine. Brain Res (1995) 0.83
The isolated allograft pouch: a useful method for monitoring small bowel allografts. Surg Forum (1971) 0.83